20 November 2013
SCI's Biotechnology Group
This event is no longer available for registration.
The Chair of the Biotechnology Group invites you to attend a memorial lecture in honour of Prof Chris Bucke who sadly passed away earlier this year, on 21 June. Chris' career extended from industry (Tate and Lyle) to academic (University of Westminster). He joined the University of Westminster in September 1985 and after many successful years he retired as Professor of Biotechnology in 2005, remaining as Emeritus Professor, where he continued advising staff and students in the School of Life Sciences.
During his career, he was a member of a number of scholarly societies including the Safety of Medicine and SCI's Biotechnology Group where he chaired the Group for many years. As editor and Editorial Board member of several journals in biotechnology, Chris with his extensive knowledge contributed actively in raising awarness of researchers to what he called 'avoid inventing the wheel'. Chris' hobbies included horticulture, travelling and particularly trekking and supporting Liverpool FC.
The Memorial Lecture will be given by Prof Bob Rastall, whose talk 'Carbohydrate bioengineering, diet and health' would've been close to Chris' heart. We are grateful for Bob for agreeing to give this lecture.
Please join us at this event and share your fond reminiscences of Chris with many of his colleagues and friends over drinks.
We have tried to be exhaustive in inviting people who knew and cared about Chris. If you know of anyone else who would appreciate coming to his event, please ask them to email us using the contact details below.
University of Westminster
Room C1.15, 1st Floor,
University of Westminster,
Faculty of Science and Technology,
115 New Cavendish Street
SCI Members attending this meeting are able to claim CPD points.
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email firstname.lastname@example.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.